Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05516108 · ClinicalTrials.gov registry record · Phase 1
Remote Mindfulness Training Following Early Life Adversity
A Phase 1 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 1
- Development phase
- 81
- Enrollment target
NCT05516108 is a Phase 1 study that has completed, run by University of Pittsburgh. The registered enrollment target is 81 participants.
The verdict
NCT05516108, a Phase 1 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 81 participants
- Enrollment target
Study Summary
This study will test the feasibility of delivering smartphone-based mindfulness and coping interventions to a sample of emerging/young adults with a history of early life adversity (ELA). 80 participants with a history of ELA will be randomly assigned to complete a two-week mindfulness training intervention or matched coping control intervention, both involving 14 foundational audio-guided lessons and practice prompts randomly delivered 3x daily. At baseline, post-intervention, and one-month follow-up lab assessments, participants will complete questionnaires and provide blood samples for assessment of markers of inflammation. Data assessing subjective and physiological stress in daily life will be collected during the intervention and for one week before, immediately after, and one month after the intervention. Passive sensor data will be continuously collected from participants' smartphones and wearable devices to develop exploratory models that estimate and predict daily life stress. Data will be used to evaluate feasibility and acceptability of interventions and assessments in an ELA sample, test effects of mindfulness training on daily life stress and markers of inflammation in an ELA sample, and develop exploratory machine learning models of stress from passive sensor data.
Interventions
- BEHAVIORAL Mindfulness
- BEHAVIORAL Coping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2024-05-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05516108
The ClinicalTrials.gov registry entry for NCT05516108 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mindfulness is the first listed.
NCT05516108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05516108 about?
NCT05516108 is a clinical study titled "Remote Mindfulness Training Following Early Life Adversity". This study will test the feasibility of delivering smartphone-based mindfulness and coping interventions to a sample of emerging/young adults with a history of early life adversity (ELA). 80 participants with a history of ELA will be randomly assigned to complete a two-week mindfulness training inte...
What is the current status of trial NCT05516108?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 81 participants. The study started on 2022-09-01. Estimated completion is 2024-05-22.
What interventions are being tested in trial NCT05516108?
The interventions under investigation include: Mindfulness (BEHAVIORAL), Coping (BEHAVIORAL).
Who is sponsoring clinical trial NCT05516108?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.